血管塞栓術の市場：塞栓術、用途、エンドユーザー別-2025-2030年の世界予測

血管塞栓術市場は、2023年に20億9,000万米ドルと評価され、2024年には23億2,000万米ドルに達すると予測され、CAGR 11.38％で成長し、2030年には44億5,000万米ドルに達すると予測されています。

血管塞栓術は、特定の部位への血流を防ぐために血管を意図的に遮断するために使用される低侵襲の医療処置です。この処置は、出血の抑制、動脈瘤の管理、血液供給を奪うことによる腫瘍の治療など、さまざまな病状の治療に不可欠です。その用途は、腫瘍学、神経学、外傷治療など様々な医療専門分野に及ぶ。最終用途の範囲には、主に病院、外来手術センター、高度な画像診断やカテーテル治療が可能な専門クリニックが含まれます。血管塞栓術市場の成長に影響を与える主な要因としては、がんや血管疾患の有病率の上昇、低侵襲技術の進歩、特殊な塞栓形成装置に対する需要の増加などが挙げられます。世界の高齢化も塞栓術の需要をさらに高めています。新興市場、医療費の増加、イメージングとマイクロカテーテル技術の技術的進歩は、大きな成長機会をもたらしています。さらに、個別化医療の採用が増加していることも、市場参入者に未開拓の可能性をもたらしています。しかし、塞栓術の手技やデバイスのコストが高いこと、熟練した専門家が限られていること、非標的塞栓などの手技に伴う潜在的な合併症などの課題に直面しています。規制当局の厳しい承認プロセスも、新製品の迅速なイントロダクションの妨げとなります。技術革新の機会は、生分解性塞栓剤の開発、より精度の高い送達システムの改良、手技の精度と安全性を高めるリアルタイム画像技術の改良にあります。企業は、研究開発への投資、先端技術を活用するための戦略的パートナーシップの形成、成長を取り込むための新興市場への進出に注力することができます。市場の特性として、高い競合と急速な技術進歩があり、持続的成長には継続的なイノベーションと戦略的計画が不可欠です。

市場力学：急速に進化する血管塞栓術市場の主要市場インサイトを公開

血管塞栓術市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 血管疾患の有病率の増加
  • 低侵襲治療への嗜好の高まり
  • 塞栓術製品および手技の開発
• 市場抑制要因
  • 塞栓術に伴う高コスト
• 市場機会
  • 血管塞栓術のための生体材料と技術の進歩
• 市場の課題
  • 塞栓術に伴う合併症

ポーターの5つの力：血管塞栓術市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：血管塞栓術市場における外部からの影響の把握

外部マクロ環境要因は、血管塞栓術市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析血管塞栓術市場における競合情勢の把握

血管塞栓術市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス血管塞栓術市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、血管塞栓術市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨血管塞栓術市場における成功への道筋を描く

血管塞栓術市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 血管疾患の罹患率の増加
    • 低侵襲手術への関心が高まる
    • 塞栓術用製品および処置の開発
  • 抑制要因
    • 塞栓術に伴う高額な費用
  • 機会
    • 血管塞栓術のバイオマテリアルとテクノロジーの進歩
  • 課題
    • 塞栓術に伴う合併症
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 血管塞栓術の市場塞栓術別

• コイル装置
• 非コイルデバイス

第7章 血管塞栓術の市場：用途別

• 神経学
• 腫瘍学
• 末梢血管疾患
• 泌尿器科

第8章 血管塞栓術の市場：エンドユーザー別

• 外来手術センター
• 診断センター
• 病院
• 専門クリニック

第9章 南北アメリカの血管塞栓術の市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の血管塞栓術の市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの血管塞栓術の市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Cook Medical Inc.
• Kaneka Corporation
• Lepu Medical Technology Co.,Ltd.
• Medtronic PLC
• Merit Medical Systems Inc.
• Penumbra Inc
• Shape Memory Medical Inc.
• Stryker Corporation
• Terumo Corporation
• W. L. Gore & Associates Inc.
• WEGO Healthcare Co., Ltd.

LIST OF FIGURES

• FIGURE 1. VASCULAR EMBOLIZATION MARKET RESEARCH PROCESS
• FIGURE 2. VASCULAR EMBOLIZATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. VASCULAR EMBOLIZATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. VASCULAR EMBOLIZATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VASCULAR EMBOLIZATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VASCULAR EMBOLIZATION MARKET DYNAMICS
• TABLE 7. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY COILING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY NON-COILING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY UROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY DIAGNOSTICS CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. CHINA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. CHINA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. INDIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. POLAND VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. POLAND VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. QATAR VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. QATAR VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. VASCULAR EMBOLIZATION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 148. VASCULAR EMBOLIZATION MARKET, FPNV POSITIONING MATRIX, 2023

The Vascular Embolization Market was valued at USD 2.09 billion in 2023, expected to reach USD 2.32 billion in 2024, and is projected to grow at a CAGR of 11.38%, to USD 4.45 billion by 2030.

Vascular embolization is a minimally invasive medical procedure used to intentionally block a blood vessel to prevent blood flow to a specific area. This procedure is vital in treating a variety of medical conditions, including controlling bleeding, managing aneurysms, and treating tumors by starving them of their blood supply. Its application spans across various medical specialties such as oncology, neurology, and trauma care. The end-use scope primarily includes hospitals, ambulatory surgical centers, and specialized clinics where advanced imaging and catheterization equipment are available. Key factors influencing the growth of the vascular embolization market include the rising prevalence of cancer and vascular diseases, advancements in minimally invasive techniques, and increasing demand for specialized embolization devices. An aging global population further fuels the demand for these procedures. Emerging markets, increasing healthcare expenditure, and technological advancements in imaging and micro-catheter technology present substantial growth opportunities. Additionally, the increasing adoption of personalized medicine offers untapped potential for market players. However, the market faces challenges such as the high cost of embolization procedures and devices, limited availability of skilled professionals, and potential complications associated with the procedure, such as non-target embolization. Stringent regulatory approval processes can also hurdle the rapid introduction of new products. Innovation opportunities lie in the development of biodegradable embolic agents, enhancing delivery systems for better precision, and improving real-time imaging technologies to increase the accuracy and safety of procedures. Businesses can focus on investing in R&D, forming strategic partnerships to leverage advanced technologies, and expanding into emerging markets to capture growth. The market's nature is characterized by high competition and rapid technological advancements, making continuous innovation and strategic planning essential for sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vascular Embolization Market

The Vascular Embolization Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of vascular diseases
  • Increasing preference for minimally invasive procedures
  • Development in embolization products and procedures
• Market Restraints
  • High costs associated with embolization procedures
• Market Opportunities
  • Advances in biomaterials and technologies for vascular embolization
• Market Challenges
  • Complications associated with embolization procedures

Porter's Five Forces: A Strategic Tool for Navigating the Vascular Embolization Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vascular Embolization Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vascular Embolization Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vascular Embolization Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vascular Embolization Market

A detailed market share analysis in the Vascular Embolization Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vascular Embolization Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vascular Embolization Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vascular Embolization Market

A strategic analysis of the Vascular Embolization Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vascular Embolization Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cook Medical Inc., Kaneka Corporation, Lepu Medical Technology Co.,Ltd., Medtronic PLC, Merit Medical Systems Inc., Penumbra Inc, Shape Memory Medical Inc., Stryker Corporation, Terumo Corporation, W. L. Gore & Associates Inc., and WEGO Healthcare Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Vascular Embolization Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Embolization Technique, market is studied across Coiling Devices and Non-Coiling Devices.
• Based on Application, market is studied across Neurology, Oncology, Peripheral Vascular Disease, and Urology.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostics Centers, Hospitals, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of vascular diseases
    • 5.1.1.2. Increasing preference for minimally invasive procedures
    • 5.1.1.3. Development in embolization products and procedures
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with embolization procedures
  • 5.1.3. Opportunities
    • 5.1.3.1. Advances in biomaterials and technologies for vascular embolization
  • 5.1.4. Challenges
    • 5.1.4.1. Complications associated with embolization procedures
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Vascular Embolization Market, by Embolization Technique

• 6.1. Introduction
• 6.2. Coiling Devices
• 6.3. Non-Coiling Devices

7. Vascular Embolization Market, by Application

• 7.1. Introduction
• 7.2. Neurology
• 7.3. Oncology
• 7.4. Peripheral Vascular Disease
• 7.5. Urology

8. Vascular Embolization Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Diagnostics Centers
• 8.4. Hospitals
• 8.5. Specialty Clinics

9. Americas Vascular Embolization Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Vascular Embolization Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Vascular Embolization Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. B. Braun Melsungen AG
• 3. Becton, Dickinson and Company
• 4. Boston Scientific Corporation
• 5. Cook Medical Inc.
• 6. Kaneka Corporation
• 7. Lepu Medical Technology Co.,Ltd.
• 8. Medtronic PLC
• 9. Merit Medical Systems Inc.
• 10. Penumbra Inc
• 11. Shape Memory Medical Inc.
• 12. Stryker Corporation
• 13. Terumo Corporation
• 14. W. L. Gore & Associates Inc.
• 15. WEGO Healthcare Co., Ltd.